Cellectis (CLLS) Gross Profit (2015 - 2023)

Cellectis' (CLLS) quarterly Gross Profit came in at $627000.0 in Q4 2023, up 1392.86% year-on-year from $42000.0 in Q4 2022, and up 395.75% quarter-over-quarter from -$212000.0 in Q3 2023.

Cellectis (CLLS) Gross Profit (2015 - 2023) Analysis & Trends

Cellectis' Gross Profit history runs 9 years deep, the most recent figure standing at $627000.0 for Q4 2023.

  • On a quarterly basis, Gross Profit rose 1392.86% year-over-year to $627000.0 in Q4 2023; TTM through Dec 2023 was $343000.0, a 60.12% decrease from a year earlier, with the FY2025 full-year figure at $72.9 million, up 75.76% from the prior year.
  • Gross Profit grew to $627000.0 in Q4 2023 per CLLS's latest filing, from -$212000.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $45.5 million in Q1 2020 and bottomed at -$5.0 million in Q4 2020.
  • The 5-year median for Gross Profit is -$126500.0 (2021), against an average of $1.9 million.
  • Across the five-year window, Gross Profit surged 11034.21% in 2019 and sank 968.55% in 2020, its largest moves.
  • Year by year, Gross Profit stood at -$1.2 million in 2019, then slumped by 306.43% to -$5.0 million in 2020, then surged by 98.78% to -$61000.0 in 2021, then jumped by 168.85% to $42000.0 in 2022, then soared by 1392.86% to $627000.0 in 2023.
  • Per Business Quant, the three latest CLLS Gross Profit figures stand at $627000.0 (Q4 2023), -$212000.0 (Q3 2023), and $123000.0 (Q2 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Cellectis 281.48 Mn 95.81 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 627,000.00
Dec 31, 2023 627,000.00
Sep 30, 2023 -212,000.00
Sep 30, 2023 -212,000.00
Jun 30, 2023 123,000.00
Jun 30, 2023 123,000.00
Mar 31, 2023 -195,000.00
Mar 31, 2023 -195,000.00
Dec 31, 2022 42,000.00
Dec 31, 2022 42,000.00
Sep 30, 2022 -192,000.00
Sep 30, 2022 -192,000.00
Jun 30, 2022 978,000.00
Jun 30, 2022 978,000.00
Mar 31, 2022 32,000.00
Mar 31, 2022 32,000.00
Dec 31, 2021 -61,000.00
Dec 31, 2021 -61,000.00
Sep 30, 2021 -901,000.00
Sep 30, 2021 -901,000.00